You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
McKinsey
Harvard Business School
Dow
AstraZeneca

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 9,663,429

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,663,429
Title:Vitamin D analogues of pharmaceutical interest
Abstract: The present invention relates to compounds of pharmaceutical interest. More particularly, it relates to compounds of formula (I), to processes for obtaining thereof, to the intermediates of their synthesis and processes for obtaining the latter. The compounds of formula (I) have a certain affinity with the vitamin D receptor, they are active in a similar order to 1,25.alpha.-dihydroxyvitamin D.sub.3 (1,25D), with the advantage of producing less or no hypercalcemia.
Inventor(s): Perez Fernandez; Roman (Santiago de Compostela, ES), Seoane Ruzo; Samuel (Santiago de Compostela, ES), Mourino Mosquera; Antonio (Santiago de Compostela, ES), Maestro Saavedra; Miguel (Santiago de Compostela, ES), Castelao Fernandez; Jose Esteban (Santiago de Compostela, ES), Gogoi; Pranjal (Santiago de Compostela, ES)
Assignee: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES)
Application Number:15/038,303
Patent Claims:see list of patent claims

Details for Patent 9,663,429

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 RX Orphan search
Dendreon Pharmaceuticals Llc PROVENGE sipuleucel-t INJECTION 125197 001 2010-04-29   Start Trial UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (Santiago de Compostela, ES) UNIVERSIDADE DA CORUNA (A Coruna, ES) SERVIZO GALEGO DE SAUDE (SERGAS) (Santiago de Compostela, ES) 2033-11-20 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
AstraZeneca
Mallinckrodt
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.